This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sigilon Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Brian Richard Fluharty: Innovator in Fabry Disease Treatment
Introduction
Brian Richard Fluharty is a notable inventor based in Boston, MA. He has made significant contributions to the field of medical treatments, particularly in addressing Fabry disease. His innovative work has led to the development of a patent that showcases his expertise and dedication to improving patient outcomes.
Latest Patents
Fluharty holds a patent titled "Compositions, Devices, and Methods for Treating Fabry Disease." This patent represents his commitment to advancing medical science and providing solutions for those affected by this rare genetic disorder. He has 1 patent to his name, reflecting his innovative contributions to the field.
Career Highlights
Fluharty is currently associated with Sigilon Therapeutics, Inc., a company focused on developing transformative therapies for patients with serious diseases. His role at Sigilon Therapeutics allows him to work on cutting-edge research and development initiatives that aim to change the landscape of treatment for various conditions.
Collaborations
Throughout his career, Fluharty has collaborated with talented individuals such as Erika Ellen Johnston and Francisco Caballero Gonzalez. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking advancements in medical treatments.
Conclusion
Brian Richard Fluharty is a dedicated inventor whose work in treating Fabry disease exemplifies the impact of innovation in healthcare. His contributions through patents and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile